In a bid to curb unethical marketing practices in the pharmaceutical industry and ensure responsible promotion of medicines, the Department of Pharmaceuticals has issued the Uniform Code of Pharmaceuticals Marketing Practices 2024 on March 12, 2024. This new regulatory framework sets clear guidelines for the interactions between doctors or registered medical practitioners (RMPs) and pharmaceutical companies, aiming to promote transparency and ethical behavior in the promotion of drugs and medical products.
About the Author
